Neil A
Acta Pharmacol Toxicol (Copenh). 1985 Feb;56(2):108-16. doi: 10.1111/j.1600-0773.1985.tb01262.x.
The binding sites labelled by 3H-dihydromorphine, 3H-ethylketocyclazocine and 3H-D-Ala2-L-Leu5-enkephalin in mouse brain membranes were characterized in cross-competition studies. The data was evaluated by simultaneous non-linear least-squares regression analysis with the "Ligand" program (Munson & Rodbard 1980), that had to be upgraded to handle more than three binding sites. By statistical analysis four different binding sites were identified. Three of the sites probably correspond to the pharmacologically well characterized mu, kappa and delta-opioid receptors, respectively, and their binding capacities relate as 1:1.5:2.5. Classification of the fourth site is more problematic. Using 3H-ethylketocyclazocine it had higher capacity than the others and bound ethylketocyclazocine with a relatively high affinity (Kd = 10 nM), dihydromorphine with a very low affinity (Kd greater than 10(-5)M) and showed no binding of D-Ala2-L-Leu5-enkephalin. In displacement studies, N-allylnorcyclazocine (SKF 10,047), though unselective, bound with highest affinity to the mu and the fourth site. Since naloxone did not bind to this fourth site, it can not be termed an opioid site in a strict sense, but it might have some relevance in view of non-naloxone-reversible effects reported for some opioids.
在交叉竞争研究中,对小鼠脑膜中由3H - 二氢吗啡、3H - 乙基酮环唑新和3H - D - 丙氨酸2 - L - 亮氨酸5 - 脑啡肽标记的结合位点进行了表征。数据通过使用“Ligand”程序(Munson和Rodbard,1980年)的同步非线性最小二乘回归分析进行评估,该程序必须升级以处理三个以上的结合位点。通过统计分析确定了四个不同的结合位点。其中三个位点可能分别对应于药理学上已充分表征的μ、κ和δ阿片受体,它们的结合能力之比为1:1.5:2.5。第四个位点的分类更具问题。使用3H - 乙基酮环唑新时,它比其他位点具有更高的容量,并且以相对较高的亲和力(Kd = 10 nM)结合乙基酮环唑新,以非常低的亲和力(Kd大于10^(-5)M)结合二氢吗啡,并且不显示D - 丙氨酸2 - L - 亮氨酸5 - 脑啡肽的结合。在置换研究中,N - 烯丙基去甲环唑新(SKF 10,047)虽然不具有选择性,但与μ和第四个位点的结合亲和力最高。由于纳洛酮不与这个第四位点结合,严格意义上它不能被称为阿片位点,但鉴于一些阿片类药物报道的非纳洛酮可逆效应,它可能具有一定相关性。